North American Long-Acting Bronchodilator Market Trends 2019 | Segmentation, Outlook, Industry Report to 2025
North American long-acting bronchodilator market was $1.5 billion in 2018 and is anticipated to grow at a substantial rate of 2.0% during the forecast period. The major factors that are contributing significantly to the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The US and Canada are the major economies of North America. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the long-acting bronchodilator market in North America. The increasing demand for long-acting bronchodilator due to increasing COPD and asthma patients in the US have endorsed the approval of cohesive reimbursement policies in the US, is further fueling the growth of the market. The US is the major market due to greater healthcare expenditure and a higher prevalence rate of respiratory diseases.
To Request a Sample of our Report on North
American Long-Acting Bronchodilator Market: https://www.omrglobal.com/request-sample/north-american-long-acting-bronchodilator-market
The North American long-acting
bronchodilator market is segmented on the basis of route of administration,
application, and end-user. Based on the route of administration, the market is
classified into oral, nasal, parenteral, and inhalation. Moreover, on the basis
of application, the market has been classified into asthma and COPD diseases.
The asthma disease application segment dominated the regional market in 2018
and is further estimated to follow the same trend over the forecast period.
This is mainly due to the high prevalence of asthma in the economies of the
region such as the US and Canada. According to the Centers for Disease Control
and Prevention (CDC) 2017, there are around 26 million asthmatics in the US,
among which, nearly 18.9 million are adults and 7.1 million are children. In
addition, based on the end-user, homecare and hospitals and clinics have been
analyzed.
(Get 15% Discount on Buying this Report)
A
full Report of North American Long-Acting Bronchodilator Market is Available
@ https://www.omrglobal.com/industry-reports/north-american-long-acting-bronchodilator-market
North American Long-Acting Bronchodilator Market Segmentation
By Route of Administration
·
Oral
·
Nasal
·
Parenteral
·
Inhalation
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Regional Analysis
·
US
·
Canada
Company Profiles
·
Adamis Pharmaceuticals Corp.
·
AstraZeneca PLC
·
Boehringer Ingelheim International GmbH
·
GlaxoSmithKline PLC
·
Novartis AG
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Sunovion Pharmaceuticals
·
Teva Pharmaceuticals Industries Ltd.
·
Vitalograph Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment